Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Review helps understand the mechanisms of R-CHOP resistance in diffuse large B-cell lymphoma

Review helps understand the mechanisms of R-CHOP resistance in diffuse large B-cell lymphoma

Researchers study the digestion process of drug-loaded DNA nanostructures in real time

Researchers study the digestion process of drug-loaded DNA nanostructures in real time

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

New gut microbiome-based approach may have translational potential for cancer immunotherapy

New gut microbiome-based approach may have translational potential for cancer immunotherapy

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Drug intervention may prevent heart damage caused by chemotherapy

Drug intervention may prevent heart damage caused by chemotherapy

Heat treatment during chemotherapy is more effective at destroying cancer cells

Heat treatment during chemotherapy is more effective at destroying cancer cells

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Low-intensity pulsed ultrasound combined with microbubbles might enhance chemotherapy delivery

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

Avacta Group announces significant progress in the development of SARS-CoV-2 rapid antigen test

Avacta Group announces significant progress in the development of SARS-CoV-2 rapid antigen test

A DNA-based nanogel for targeted delivery of therapeutics

A DNA-based nanogel for targeted delivery of therapeutics

A promising vaccine for treating poorly immunogenic tumors

A promising vaccine for treating poorly immunogenic tumors

Novel 3D-printed scaffold loaded with chemotherapy drug could reduce breast cancer recurrence

Novel 3D-printed scaffold loaded with chemotherapy drug could reduce breast cancer recurrence

Nanoparticles release bursts of calcium to reverse multidrug resistance in tumor cells

Nanoparticles release bursts of calcium to reverse multidrug resistance in tumor cells

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Cancer chemotherapy changes the function of cells that repair heart injury

Cancer chemotherapy changes the function of cells that repair heart injury

Novel liver cancer treatment could shrink tumors in a mouse model

Novel liver cancer treatment could shrink tumors in a mouse model

Brazilian red propolis contains substances with anti-cancer properties

Brazilian red propolis contains substances with anti-cancer properties